期刊文献+

低钙透析液在腹膜透析中的应用 被引量:1

下载PDF
导出
摘要 腹膜透析 (PD)目前是治疗终末期肾病的主要措施之一。而传统腹透液 ( 1.75mmol/L、3 .5mEq/L)是一种非生理性的高钙溶液。近年来 ,随着活性维生素D及含钙磷结合剂的广泛使用 ,高钙血症及继发的血管和软组织钙化成为突出的问题。因此 ,多数学者建议降低腹透液中的钙浓度以减少上述并发症的发生。本文拟就为什么使用低钙透析液。
作者 李岩 李军
出处 《国外医学(泌尿系统分册)》 2005年第2期237-240,共4页 Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
关键词 腹膜透析
  • 相关文献

参考文献22

  • 1BarryM.Brenner.BrennerRector''s The kidney,vol(2)[M].北京:科学出版社,2001年第一版.pp2459-2450.
  • 2钱莹,陈楠.骨保护素和肾性骨病[J].中国实用内科杂志,2004,24(7):444-445. 被引量:12
  • 3Kates DM, Andress DL. Control of hyperpbosphatemia in renal failure:Role of aluminum. Semin Dial, 1996,9: 310 - 315.
  • 4Goodman WG,Goldin J,Kuizon BD, et al. Coronary- artery calcification in young adults with end - stage renal disease who are undergoing dialysis. N Engl J Med,2000,342:1478-1483.
  • 5Brancaccio D, Tetta C, Gallieni M, et al. Inflammation, CRP, calcium overload and a high calcium- phosphate product: A"liaison dangereuse."Nephrol Dial Transplent,2000,17:201 - 203.
  • 6Malberti F, Ravani P. Disturbances of mineral metabolism and vascular calcifications in dialysis patients. G Ital Nefrol,2004,21(3):238- 44.
  • 7Ole Simonsen, Dauiele Venturoli, Anoers Wieslander, et al. Mass transfer of calcium across the peritoneum at three different peritoneal dialysis fluid Ca2+ and glucose concentrations. Kidney Int,2003,(64):208-215.
  • 8Yokoyama K,Kagami S, Ohkido I,et al. The negative Ca(2 + ) balance is involved in the stimulation of PTH secretion. Nephron,2002,92(1):86-90.
  • 9Brandi L, Nielsen PK, Bro S, et al. Long- term effects of intermittent oral alphacalcidol, calcium carbonate and low- calcium dialysis(1.25 mmool/L) on socondnry hyperparathyroidism in patients on continous ambulatory peritoneal dialysis. J Inter Med, 1998,244:121 - 131.
  • 10Weinreich T,Passlick- Deetjon J,Ritz E. Collaborators of the peritoneal dialysis multicenter study group: Low dialysate calcium in continuous ambulatory peritoneal dialysis: A randinized controlled multicenter trial.Am J Kidney Dis, 1995,25:452- 460.

二级参考文献10

  • 1Lee SK, Lorenzo JA. Parathyroid hormone stimulates TRANCE and inhibits osteoprotagerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology, 1999,140(1):3552-3561
  • 2Coen G, Ballanti P, Balducci A,et al. Serum osteoprotegerin and renal osteodystrophy. Nephrol Dial Transplant,2002,17(3):233-238
  • 3Hass M, Leko-Mohr Z, Roschger P, et al. Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients. Am J Kidney Dis ,2002,39(3):580-586
  • 4Bekker PJ, Holloway D, Nakanishi A, et al. The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res ,2001,169(2)348-360
  • 5Qi Q, Monier-Faugere MC, Geng Z, et al. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis, 1995,26(4):622-631
  • 6Gonzalez EA. The role of cytokines in skeletal remodelling:possible consequences for renal osteodystrophy. Nephrol Dial Transplant,2000,15(5) :945-950
  • 7Bucay N,Sarosi I, Dunstan CR,et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev,1998,12(6):1260-1268
  • 8Akatsu T, Murakami T, Nishikawa M, et al. Osteoclastogenesis inhibitory in the interaction of stromal cells with osteoclast. Biochem Biophys Res Commun,1998,250(2) :229-234
  • 9廖二元,周后德,邓小戈,张湘生,彭建,伍贤平.雌二醇对成骨细胞护骨素基因表达的影响[J].中华内分泌代谢杂志,2001,17(4):242-245. 被引量:14
  • 10钱莹,陈楠,朱萍,汪关煜,周同,李娅,王伟铭.人甲状旁腺素对新生大鼠成骨细胞护骨素基因表达的影响[J].中国微循环,2004,8(2):75-78. 被引量:4

共引文献11

同被引文献5

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部